Pranam
THE PHARMACEUTICAL INDUSTRY: A KEY ASSET TO THE EUROPEAN ECONOMY (this
will reveal the marketing)
As well as driving medical progress by researching, developing and
bringing new medicines that improve health and quality of life for patients
around the world, the research-based pharmaceutical industry is a key asset
of the European economy. It is one of Europe’s top performing
high-technology sectors.
INDUSTRY (EFPIA total) 2000 2010 2017
2018
Production 127,504 199,400 250,868
260,000
(e) Exports (1) (2) 90,935 276,357 396,036
410,000
(e) Imports 68,841 204,824
294,632 305,000
(e) Trade balance 22,094 71,533 101,404
105,000
(e) R&D expenditure 17,849 27,920
35,318 36,500
(e) Employment (units) 554,186 670,088 760,795
765,000
(e) R&D employment (units) 88,397 117,035 114,655
115,000
(e) Total pharmaceutical
market value at
ex-factory prices 89,449 153,685
208,949 220,000
(e) Payment for
pharmaceuticals by
statutory health
insurance systems
(ambulatory care only) 76,909 129,464
133,775 137,000
(e) Values in € million unless otherwise stated
(1) Data relate to EU-27, Norway and Switzerland since 2005 (EU-15 before
2005); Croatia and Serbia included since 2010; Turkey included since 2011;
Russia included since 2013
(2) Data relating to total exports and total imports include EU-28
intra-trade (double counting in some cases) Source: EFPIA member
associations (official figures) - (e): EFPIA estimate; Eurostat (EU-28
trade data 2000-2018) .
In the US, Pfizer leads in sales revenues of about $45 billion
USD in 2013 while Johnson & Johnson realized a revenue of $70,074 million
USD in 2015. In Switzerland, Novartis made $47,101 million in revenues in
2014 while Roche realized $39,120 million USD in the same year. In France,
Sanofi made $36,437 million USD in 2014 while in Japan, Takeda made $20,446
million USD in 2014. Bayer in Germany made $15,486 million USD in 2014. The
US has the largest pharmaceutical market in the world with a value of
$339,694 million USD followed by Japan
<https://www.worldatlas.com/maps/japan> ($94,025 million USD) and China
($86,774 million USD). In Germany, the value of its pharmaceutical market
is about $45,828 million USD and in France
<https://www.worldatlas.com/maps/france>, it is about $37,156 million USD.
In Brazil, the value of its pharmaceutical market is about $30,670 million
USD. In Italy, the value is about $27,930 million USD. In the UK, it is
about $24,513 million USD while in Canada it is about $21,353 million USD.
In Spain, it is about $20,741 million USD. KR IRS 16122
On Sun, 16 Jan 2022 at 00:58, Srinivasan Sridharan <
[email protected]> wrote:
>
>
> Sent from my iPhone
>
> Begin forwarded message:
>
> *From:* Srinivasan Sridharan <[email protected]>
> *Date:* January 15, 2022 at 9:41:15 AM PST
> *To:* srinivasan sridharan <[email protected]>
> *Subject:* *Pharma's lobby !*
>
>
> https://www.youtube.com/watch?v=XCciAJJMt9Q
>
>
--
You received this message because you are subscribed to the Google Groups
"Thatha_Patty" group.
To unsubscribe from this group and stop receiving emails from it, send an email
to [email protected].
To view this discussion on the web visit
https://groups.google.com/d/msgid/thatha_patty/CAL5XZorbrAbmHfcOtYp_39HThSk_QDO3CM-LzGtUNFjswtVAAA%40mail.gmail.com.
